Literature DB >> 16415532

Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs.

Susumu Imaoka1, Takanori Hashizume, Yoshihiko Funae.   

Abstract

Metabolites of arachidonic acid produced by P450 are interesting substances with prominent physiological functions. To elucidate the physiological function of P450, it is necessary to identify a specific P450 in a particular tissue or organ and to characterize its catalytic activities. In this study, the expression of CYP2A1, 2B1, 2C23, 2J3, and 4F1 was investigated in liver, lung, kidney, spleen, heart, brain, and testis of rats by RT-PCR. Furthermore, arachidonic acid metabolism was investigated using the rat P450s described above and human CYP2A6, 2B6, 2C9, 2C18, 2C19, 2J2, and 4F2. Among the rat P450s, CYP2B1 and 2C23 efficiently produced EETs and CYP4F1 produced 19/20-HETE in abundace. CYP2B1 was specifically expressed in the lung. CYP2C23 was detected in all tissues used in this study. CYP4F1 was expressed in the kidney as well as in the liver. Among the human P450s, CYP2C9 and 2C19 efficiently produced EETs. CYP4F2 produced 19/20-HETE. The catalytic properties of rat CYP2C23 were similar to those of human CYP2C9 and 2C19. The catalytic properties of CYP4F isoforms were also similar between humans and rats. A systematic analysis of P450 expression in various tissues and of its catalytic property may provide valuable information on the physiological roles of P450s in each tissue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16415532     DOI: 10.2133/dmpk.20.478

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  18 in total

1.  Effects of acetylenic epoxygenase inhibitors on recombinant cytochrome p450s.

Authors:  Melissa A VanAlstine; Lindsay B Hough
Journal:  Drug Metab Dispos       Date:  2011-04-01       Impact factor: 3.922

Review 2.  The role of dyslipidemia in diabetic retinopathy.

Authors:  Sandra S Hammer; Julia V Busik
Journal:  Vision Res       Date:  2017-05-26       Impact factor: 1.886

3.  Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists.

Authors:  Kasem Nithipatikom; Daniel M Brody; Alan T Tang; Vijaya L Manthati; John R Falck; Carol L Williams; William B Campbell
Journal:  Cancer Sci       Date:  2010-08-27       Impact factor: 6.716

4.  7alpha-hydroxytestosterone affects 1 beta-hydroxysteroid dehydrogenase 1 direction in rat Leydig cells.

Authors:  Guo-Xin Hu; Qing-Quan Lian; Bing-Bing Chen; Pramod V Prasad; Narender Kumar; Zhi-Qiang Zheng; Ren-Shan Ge
Journal:  Endocrinology       Date:  2009-12-16       Impact factor: 4.736

5.  Regulatory mechanisms to control tissue alpha-tocopherol.

Authors:  Debbie J Mustacich; Anh T Vo; Valerie D Elias; Katie Payne; Laura Sullivan; Scott W Leonard; Maret G Traber
Journal:  Free Radic Biol Med       Date:  2007-05-31       Impact factor: 7.376

6.  The role of cytochrome P450 epoxygenases in retinal angiogenesis.

Authors:  Megan E Capozzi; Gary W McCollum; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-10       Impact factor: 4.799

Review 7.  20-HETE in the regulation of vascular and cardiac function.

Authors:  Petra Rocic; Michal Laniado Schwartzman
Journal:  Pharmacol Ther       Date:  2018-07-23       Impact factor: 12.310

Review 8.  Epoxyeicosanoid signaling in CNS function and disease.

Authors:  Jeffrey J Iliff; Jia Jia; Jonathan Nelson; Toru Goyagi; Judy Klaus; Nabil J Alkayed
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-06-21       Impact factor: 3.072

9.  Determination of the dominant arachidonic acid cytochrome p450 monooxygenases in rat heart, lung, kidney, and liver: protein expression and metabolite kinetics.

Authors:  Ahmed A El-Sherbeni; Mona E Aboutabl; Beshay N M Zordoky; Anwar Anwar-Mohamed; Ayman O S El-Kadi
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

10.  Drug-virus interaction: effect of administration of recombinant adenoviruses on the pharmacokinetics of docetaxel in a rat model.

Authors:  P Wonganan; W C Zamboni; S Strychor; J D Dekker; M A Croyle
Journal:  Cancer Gene Ther       Date:  2008-12-26       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.